Optimal treatment for preventing recurrent stroke in hypertensives

Phase 1

• Conditions: Patients with arterial hypertension and previous stroke or transient ischemic attack; MedDRA version: 15.0Level: SOCClassification code 10047065Term: Vascular disordersSystem Organ Class: 10047065 - Vascular disorders; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2012-001757-21-IT
• Lead Sponsor: ISTITUTO AUXOLOGICO ITALIANO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-08-31
• Last Update Posted: 17 August 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 7500

Inclusion Criteria

- Stroke or transient ischemic attack 1 to 6 months previous to randomization; - 65 years and above; - Only hypertensive patients; - Patients without statin treatment with LDL-cholesterol > 2.8 mmol/l; - Patients on statin treatment with any LDL-cholesterol value
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 7500

Exclusion Criteria

- Patients in unstable clinical conditions; - Patients with haemodynamically significant carotid stenosis or requiring carotid revascularization.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified